Montreux Equity Partners IV, L.P. 4
4 · SI-BONE, Inc. · Filed Oct 19, 2018
Insider Transaction Report
Form 4
SI-BONE, Inc.SIBN
Montreux Equity Partners IV, L.P.
10% Owner
Transactions
- Conversion
Series 6 Preferred Stock
2018-10-19−563,926→ 0 total(indirect: By Montreux Equity Partners IV, L.P.)→ Common Stock (597,071 underlying) - Conversion
Series 6 Preferred Stock
2018-10-19−48,950→ 0 total(indirect: By LLC)→ Common Stock (51,827 underlying) - Conversion
Series 7 Preferred Stock
2018-10-19−27,409→ 0 total(indirect: By Montreux Equity Partners IV, L.P.)→ Common Stock (27,409 underlying) - Conversion
Common Stock
2018-10-19+1,102,915→ 1,102,915 total(indirect: By Montreux Equity Partners IV, L.P.) - Conversion
Common Stock
2018-10-19+597,071→ 1,699,986 total(indirect: By Montreux Equity Partners IV, L.P.) - Conversion
Common Stock
2018-10-19+27,409→ 1,727,395 total(indirect: By Montreux Equity Partners IV, L.P.) - Conversion
Common Stock
2018-10-19+78,564→ 78,564 total(indirect: By LLC) - Sale
Series 5 Preferred Stock
2018-10-19$15.00/sh−9,397$140,955→ 1,102,915 total(indirect: By Montreux Equity Partners IV, L.P.)→ Common Stock (9,397 underlying) - Conversion
Series 5 Preferred Stock
2018-10-19−78,564→ 0 total(indirect: By LLC)→ Common Stock (78,564 underlying) - Conversion
Common Stock
2018-10-19+171,929→ 171,929 total(indirect: By LLC) - Exercise of In-Money
Series 5 Preferred Stock
2018-10-19+15,496→ 1,112,312 total(indirect: By Montreux Equity Partners IV, L.P.)Exercise: $9.10→ Common Stock (15,496 underlying) - Conversion
Series 5 Preferred Stock
2018-10-19−1,102,915→ 0 total(indirect: By Montreux Equity Partners IV, L.P.)→ Common Stock (1,102,915 underlying) - Conversion
Series 7 Preferred Stock
2018-10-19−171,929→ 0 total(indirect: By LLC)→ Common Stock (171,929 underlying) - Conversion
Common Stock
2018-10-19+51,827→ 130,391 total(indirect: By LLC) - Exercise of In-Money
Warrant (right to buy)
2018-10-19−15,496→ 0 total(indirect: By Montreux Equity Partners IV, L.P.)Exercise: $9.10→ Series 5 Preferred Stock (15,496 underlying)
Footnotes (5)
- [F1]The Issuer's Series 5 Preferred Stock and Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
- [F2]Montreux Equity Management IV, L.L.C. ("MEM IV LLC") is the general partner of each of Montreux Equity Partners IV, L.P., Montreux IV Associates, L.L.C and Montreux IV Associates IV, L.L.C. Daniel K. Turner III is the managing director of MEM IV LLC and may be deemed to have voting and investment power over the shares held by each of these entities. Mr. Turner disclaims beneficial ownership of such shares, except to the extent of his proportionate pecuniary interest, if any.
- [F3]The Issuer's Series 6 Preferred Stock automatically converted into approximately 1.05878 shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
- [F4]Shares subject to the warrant are immediately exercisable. The warrant will expire in connection with the closing of the Issuer's initial public offering.
- [F5]Immediately prior to the closing of the Issuer's initial public offering, Montreux Equity Partners IV, L.P. exercised a warrant to purchase 15,496 shares of Series 5 Preferred Stock at an exercise price of $9.10 per share. The exercise price was paid on a net exercise cashless basis calculated using the Issuer's initial public offering price of $15.00, resulting in the Issuer withholding 9,397 of the warrant shares to pay the exercise price and issuing MEP the remaining 6,099 shares.